| EP3663296 - PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL FOR TREATING SPINAL MUSCULAR ATROPHY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.03.2024 Database last updated on 26.03.2026 | |
| Former | The patent has been granted Status updated on 14.04.2023 | ||
| Former | Grant of patent is intended Status updated on 06.12.2022 | ||
| Former | Examination is in progress Status updated on 24.12.2021 | ||
| Former | Request for examination was made Status updated on 11.12.2020 | ||
| Former | The application has been published Status updated on 08.05.2020 | Most recent event Tooltip | 05.09.2025 | Lapse of the patent in a contracting state New state(s): CY, HU | published on 08.10.2025 [2025/41] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | For all designated states PTC Therapeutics, Inc. 100 Corporate Court South Plainfield, NJ 07080 / US | [2020/24] | Inventor(s) | 01 /
RATNI, Hasane 4 Louis Pasteur 68440 Habsheim / FR | 02 /
GREEN, Luke Jungstrasse 20 4056 Basel / CH | 03 /
NARYSHKIN, Nikolai A. 101 Windsong Circle East Brunswick, NJ 08816 / US | 04 /
WEETALL, Marla L. 70 Burnham Parkway Morristown, NJ 07960 / US | [2020/24] | Representative(s) | Schirlin, Julien F. Hoffmann-La Roche AG CLP - Patent Department Grenzacherstrasse 124 4070 Basel / CH | [2020/24] | Application number, filing date | 19200058.6 | 11.05.2015 | [2020/24] | Priority number, date | US201461993839P | 15.05.2014 Original published format: US 201461993839 P | [2020/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3663296 | Date: | 10.06.2020 | Language: | EN | [2020/24] | Type: | B1 Patent specification | No.: | EP3663296 | Date: | 17.05.2023 | Language: | EN | [2023/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.05.2020 | Classification | IPC: | C07D487/04, C07D519/00, A61K31/5025, // A61P21/00 | [2020/24] | CPC: |
A61P21/00 (EP,EA);
C07D519/00 (EP,CN,EA,IL,US);
C07D487/04 (EP,EA,IL,KR,US);
A61K31/5025 (EA,KR);
A61K31/519 (KR);
A61P21/02 (EP,EA);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/02] |
| Former [2020/24] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Validation states | MA | 10.12.2020 | Title | German: | VERFAHREN ZUR HERSTELLUNG VON VERBINDUNGEN ZUR BEHANDLUNG VON SPINALER MUSKELATROPHIE | [2020/24] | English: | PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL FOR TREATING SPINAL MUSCULAR ATROPHY | [2020/24] | French: | PROCÉDÉ POUR LA PRÉPARATION DE COMPOSÉS UTILES À TRAITER L'AMYOTROPHIE SPINALE | [2020/24] | Examination procedure | 09.12.2020 | Amendment by applicant (claims and/or description) | 09.12.2020 | Examination requested [2021/02] | 09.12.2020 | Date on which the examining division has become responsible | 23.12.2021 | Despatch of a communication from the examining division (Time limit: M06) | 24.06.2022 | Reply to a communication from the examining division | 07.12.2022 | Communication of intention to grant the patent | 05.04.2023 | Fee for grant paid | 05.04.2023 | Fee for publishing/printing paid | 05.04.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP15721701.9 / EP3143025 | Divisional application(s) | EP23169721.0 / EP4241772 | Opposition(s) | 20.02.2024 | No opposition filed within time limit [2024/17] | Fees paid | Renewal fee | 27.01.2020 | Renewal fee patent year 03 | 27.01.2020 | Renewal fee patent year 04 | 19.11.2019 | Renewal fee patent year 05 | 30.03.2020 | Renewal fee patent year 06 | 11.05.2021 | Renewal fee patent year 07 | 21.03.2022 | Renewal fee patent year 08 | 21.03.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 11.05.2015 | HU | 11.05.2015 | BG | 17.05.2023 | CZ | 17.05.2023 | DK | 17.05.2023 | EE | 17.05.2023 | FI | 17.05.2023 | LT | 17.05.2023 | LV | 17.05.2023 | MC | 17.05.2023 | RS | 17.05.2023 | SK | 17.05.2023 | SM | 17.05.2023 | NO | 17.08.2023 | IS | 17.09.2023 | PT | 18.09.2023 | [2025/41] |
| Former [2025/07] | BG | 17.05.2023 | |
| CZ | 17.05.2023 | ||
| DK | 17.05.2023 | ||
| EE | 17.05.2023 | ||
| FI | 17.05.2023 | ||
| LT | 17.05.2023 | ||
| LV | 17.05.2023 | ||
| MC | 17.05.2023 | ||
| RS | 17.05.2023 | ||
| SK | 17.05.2023 | ||
| SM | 17.05.2023 | ||
| NO | 17.08.2023 | ||
| IS | 17.09.2023 | ||
| PT | 18.09.2023 | ||
| Former [2024/51] | BG | 17.05.2023 | |
| CZ | 17.05.2023 | ||
| DK | 17.05.2023 | ||
| EE | 17.05.2023 | ||
| FI | 17.05.2023 | ||
| LT | 17.05.2023 | ||
| LV | 17.05.2023 | ||
| RS | 17.05.2023 | ||
| SK | 17.05.2023 | ||
| SM | 17.05.2023 | ||
| NO | 17.08.2023 | ||
| IS | 17.09.2023 | ||
| PT | 18.09.2023 | ||
| Former [2024/10] | CZ | 17.05.2023 | |
| DK | 17.05.2023 | ||
| EE | 17.05.2023 | ||
| FI | 17.05.2023 | ||
| LT | 17.05.2023 | ||
| LV | 17.05.2023 | ||
| RS | 17.05.2023 | ||
| SK | 17.05.2023 | ||
| SM | 17.05.2023 | ||
| NO | 17.08.2023 | ||
| IS | 17.09.2023 | ||
| PT | 18.09.2023 | ||
| Former [2024/08] | FI | 17.05.2023 | |
| LT | 17.05.2023 | ||
| LV | 17.05.2023 | ||
| RS | 17.05.2023 | ||
| SK | 17.05.2023 | ||
| SM | 17.05.2023 | ||
| NO | 17.08.2023 | ||
| IS | 17.09.2023 | ||
| PT | 18.09.2023 | ||
| Former [2024/03] | FI | 17.05.2023 | |
| LT | 17.05.2023 | ||
| LV | 17.05.2023 | ||
| RS | 17.05.2023 | ||
| NO | 17.08.2023 | ||
| IS | 17.09.2023 | ||
| PT | 18.09.2023 | ||
| Former [2024/01] | LT | 17.05.2023 | |
| LV | 17.05.2023 | ||
| RS | 17.05.2023 | ||
| NO | 17.08.2023 | ||
| IS | 17.09.2023 | ||
| PT | 18.09.2023 | ||
| Former [2023/51] | RS | 17.05.2023 | |
| NO | 17.08.2023 | ||
| IS | 17.09.2023 | ||
| PT | 18.09.2023 | ||
| Former [2023/50] | NO | 17.08.2023 | |
| IS | 17.09.2023 | ||
| PT | 18.09.2023 | ||
| Former [2023/48] | NO | 17.08.2023 | |
| PT | 18.09.2023 | ||
| Former [2023/46] | PT | 18.09.2023 | Documents cited: | Search | [AD] WO2013119916 (PTC THERAPEUTICS INC et al.) | [AD] WO2010019326 (CARDIAC PACEMAKERS INC et al.) | [AD] WO2009151546 (PTC THERAPEUTICS INC et al.) | by applicant | WO2009151546 | WO2010019236 | WO2013119916 | CRAWFORDPARDO, NEUROBIOL. DIS., vol. 3, 1996, pages 97 | LE ET AL., HUM. MOL. GENET., vol. 14, 2005, pages 845 | PASSINI ET AL., SCI. TRANSL. MED., vol. 3, 2011, pages 72ra18 | HUA ET AL., NATURE, vol. 478, 2011, pages 123 | COADYLORSON, J NEUROSCI., vol. 30, 2010, pages 126 | "McGraw-Hill Dictionary of Chemical Terms", 1984, MCGRAW-HILL BOOK COMPANY | ELIEL, E.WILEN, S.: "Stereochemistry of Organic Compounds", 1994, JOHN WILEY & SONS, INC. | CAHN ET AL., ANGEW. CHEM. INTER. EDIT., vol. 5, 1966, pages 385 | F. MILLETTI ET AL., J. CHEM. INF. MODEL, vol. 47, 2007, pages 2172 - 2181 | ANSEL H. C. ET AL.: "Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems", 2004, LIPPINCOTT, WILLIAMS & WILKINS | GENNARO A.R. ET AL.: "Remington: The Science and Practice of Pharmacy", 2000, LIPPINCOTT, WILLIAMS & WILKINS | ROWE R.C: "Handbook of Pharmaceutical Excipients", 2005, PHARMACEUTICAL PRESS | LIVAKSCHMITTGEN, METHODS, vol. 25, 2001, pages 402 - 8 |